Abbott Laboratories
ABT
Revenue
10.36B
▼-616.00M▼-5.61%
3 Months ChangeAssets
81.45B
▲34.00M▲0.04176%
3 Months ChangeLiabilities
32.64B
▼-1.11B▼-3.30%
3 Months ChangeFree Cash Flow
933.00M
▲306.00M▲48.80%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001628280-24-044602
2024-10-16
Form 8-K
ID: 0001628280-24-042893
2024-07-31
Form 10-Q
ID: 0001628280-24-033740
2024-07-18
Form 8-K
ID: 0001628280-24-032182
2024-05-02
Form 10-Q
ID: 0001628280-24-020011
2024-05-01
Form 8-K
ID: 0001104659-24-055724
2024-04-29
Form 8-K
ID: 0001104659-24-054016
2024-04-17
Form 8-K
ID: 0001628280-24-016497
2024-01-29
Form 8-K
ID: 0001104659-24-007725
2024-01-24
Form 8-K
ID: 0001628280-24-002009